DIN 02517019 — MAR-AFATINIB 20 MG
MAR-AFATINIB is a tablet of Afatinib marketed by MARCAN PHARMACEUTICALS INC. The full Afatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02517019
- Brand name
- MAR-AFATINIB
- Active ingredient
- Afatinib
- Strength
- 20 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- MARCAN PHARMACEUTICALS INC
- Health Canada status
- MARKETED
- Drug class
- Protein kinase inhibitor (irreversible ErbB family / EGFR tyrosine kinase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Afatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02415666 | GIOTRIF | 20 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02415674 | GIOTRIF | 30 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02415682 | GIOTRIF | 40 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02517027 | MAR-AFATINIB | 30 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02517035 | MAR-AFATINIB | 40 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02512777 | SANDOZ AFATINIB | 20 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02512785 | SANDOZ AFATINIB | 30 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02512793 | SANDOZ AFATINIB | 40 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |